On July 9, 2023, the clinical first research meeting of the 'Additive Manufacturing Porous Absorbable Artificial Bone' project of T-Bright (Kunshan) Biotechnology Co., Ltd. was successfully held at the Novotel Hotel in Kunshan.

The project has basically completed all laboratory research work, passed all 10 biocompatibility tests and product type inspections, obtained valid data from animal experiments for one and a half years, and completed one scientific research clinical trial.

The six clinical trial institutions participating in the first research meeting were: the First Affiliated Hospital of Suzhou University (team leader), the Fourth Medical Center of 301 Hospital, the Sixth People's Hospital of Shanghai Jiaotong University, the Ninth People's Hospital of Shanghai Jiaotong University, Quzhou People's Hospital, and Lishui People's Hospital.

The attending experts had a serious and thorough exchange and discussion about the clinical trial plan, and reached a consensus. CRO company will summarize the opinions to form the final clinical trial plan and officially implement the human clinical trial as soon as possible.